Delivery Order SPE2DB24D1021-SPE2DB25FEXMB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nexletol 180 mg tablets (30-unit packaging) valued at $1,389.23. This competitively awarded, firm fixed-price delivery order is non-set-aside and has a completion date of July 31, 2025. The award is issued to AmerisourceBergen Drug Corp's Corporate Office, with performance taking place at the company's Conshohocken, Pennsylvania headquarters, which serves as a major hub for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order carries a ceiling value of $1,269.01 and has an ultimate completion date of August 19, 2025. The contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,250.17 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Nexletol 180 mg on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) on September 2, 2025, with a ceiling value of $2,667.56 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,208.72 for NEXLETOL 180 mg tablets (30-count units) with an ultimate completion date of July 11, 2025. This is a firm fixed-price, non-set-aside contract performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $2,172.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) with an ultimate completion date of September 24, 2025. This non-set-aside award was issued on September 23, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,216.50, is non-competitive and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The award represents a single pharmaceutical product delivery under the company's...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DB22D3004|SPE2DB24FPZ07) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Nexletol 180 mg tablets. The $1,017.34 award has an ultimate completion date of April 15, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on a Firm Fixed Price contract. The order is for 4567888111 NEXLETOL 180 MG TABLET UU 30S and has a ceiling value of $1,201.20. The ultimate completion date is April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,001.00, is scheduled for completion by June 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the company's competitive...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXMBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Nexletol 180 mg tablets (30-count units) with a contract ceiling value of $1,216.14. This firm fixed-price delivery order, which carries an ultimate completion date of June 6, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's supply chain. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The DLA Troop Support is concurrently planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/5/25 |